Arcellx (NASDAQ:ACLX) advances modular cell therapy platforms, appearing in biotech discussions shaped by the nasdaq ...
Every aspirant who is going to sit in the Graduate Aptitude Test in Engineering (GATE) Biotechnology (BT) exam 2026 must ...
While Kartik Aaryan quietly completed a decade-long BTech journey, Ananya Panday moved from Mumbai to LA before choosing cinema over classrooms., Education, Times Now ...
A study led by researchers at the Department of Civil Engineering at The University of Hong Kong (HKU) has uncovered alarming ...
Interesting Engineering on MSN
Top 7 must-read stories of 2025 — Interesting Engineering
The top 7 must-read stories from Interesting Engineering cover humanoids that box, lasers to kill mosquitoes, and even an ...
Under the ongoing collaboration Remedy Cell’s personnel, along with Pluri’s Contract Development and Manufacturing Organization (“CDMO”) division (PluriCDMO™), have successfully completed the full ...
The company plans to announce Phase 1b interim data by mid-2026, and the TENACITY-01 study is expected to be completed by late 2028. This timing enables progression to Phase 2 evaluation following ...
Seven scientists and researchers involved in biotechnology were recognized with the distinguished Filipino Faces of Biotechnology Award, which celebrated its 10th year, at a hotel in Manila on ...
SIT Pune is now accepting applications for its B.Tech programmes for the 2026-27 academic year. Admission requires completion of 10+2 with specified subjects.
Newspoint on MSN
Career: Chemical or biochemical engineering? Which branch will offer a better career after 12th grade?
Engineering has always been a top choice for students in India. While there were only 5 to 6 main branches of engineering in the past, today there are more than 40 different types of engineering ...
Vor Biopharma Inc. (Nasdaq: VOR), a clinical-stage biotechnology company dedicated to transforming the treatment of autoimmune diseases, today announced the appointment of Andrew Levin, M.D., Ph.D., ...
Scientists at MIT and Stanford have unveiled a promising new way to help the immune system recognize and attack cancer cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results